These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21850227)

  • 21. UV but not gamma irradiation accelerates p53-induced apoptosis of teratocarcinoma cells by repressing MDM2 transcription.
    Zeng X; Keller D; Wu L; Lu H
    Cancer Res; 2000 Nov; 60(21):6184-8. PubMed ID: 11085543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competitive ubiquitination activates the tumor suppressor p53.
    Li X; Guo M; Cai L; Du T; Liu Y; Ding HF; Wang H; Zhang J; Chen X; Yan C
    Cell Death Differ; 2020 Jun; 27(6):1807-1818. PubMed ID: 31796886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma.
    Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G
    Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying the determinants of response to MDM2 inhibition.
    Saiki AY; Caenepeel S; Cosgrove E; Su C; Boedigheimer M; Oliner JD
    Oncotarget; 2015 Apr; 6(10):7701-12. PubMed ID: 25730903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage.
    Batchelor E; Mock CS; Bhan I; Loewer A; Lahav G
    Mol Cell; 2008 May; 30(3):277-89. PubMed ID: 18471974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
    Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J
    Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dynamical model on the network of p53-Mdm2 feedback loop regulated by p14/19ARF.
    Liu H; Han YR; Zhan Y; Chen YF; Zhang YH; Yu H; Zhao TJ; Zhuo YZ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4235-8. PubMed ID: 18002937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions.
    Sang P; Shi Y; Lu J; Chen L; Yang L; Borcherds W; Abdulkadir S; Li Q; Daughdrill G; Chen J; Cai J
    J Med Chem; 2020 Feb; 63(3):975-986. PubMed ID: 31971801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.
    Deisenroth C; Thorner AR; Enomoto T; Perou CM; Zhang Y
    Mol Cell Biol; 2010 Aug; 30(16):3981-93. PubMed ID: 20547751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells.
    Wade M; Li YC; Matani AS; Braun SM; Milanesi F; Rodewald LW; Wahl GM
    Oncogene; 2012 Nov; 31(45):4789-97. PubMed ID: 22266850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of SCY45, a Natural Small-Molecule MDM2-p53 Interaction Inhibitor.
    Gong H; An J; Dong Q; Li J; Yang W; Sun W; Su Z; Zhang S
    Chem Biodivers; 2019 Jun; 16(6):e1900081. PubMed ID: 30989812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the MDM2-p53 interaction for cancer therapy.
    Shangary S; Wang S
    Clin Cancer Res; 2008 Sep; 14(17):5318-24. PubMed ID: 18765522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From structure to dynamics: frequency tuning in the p53-Mdm2 network. II Differential and stochastic approaches.
    Ouattara DA; Abou-Jaoudé W; Kaufman M
    J Theor Biol; 2010 Jun; 264(4):1177-89. PubMed ID: 20346959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypes.
    Arva NC; Talbott KE; Okoro DR; Brekman A; Qiu WG; Bargonetti J
    Ethn Dis; 2008; 18(2 Suppl 2):S2-1-8. PubMed ID: 18646312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
    Becker K; Marchenko ND; Palacios G; Moll UM
    Cell Cycle; 2008 May; 7(9):1205-13. PubMed ID: 18418047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway.
    Thotala DK; Hallahan DE; Yazlovitskaya EM
    Cell Death Differ; 2012 Mar; 19(3):387-96. PubMed ID: 21738215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.
    O'Connor PM; Jackman J; Bae I; Myers TG; Fan S; Mutoh M; Scudiero DA; Monks A; Sausville EA; Weinstein JN; Friend S; Fornace AJ; Kohn KW
    Cancer Res; 1997 Oct; 57(19):4285-300. PubMed ID: 9331090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis.
    Ji H; Ding Z; Hawke D; Xing D; Jiang BH; Mills GB; Lu Z
    EMBO Rep; 2012 Jun; 13(6):554-60. PubMed ID: 22510990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.